Processed Excipients in Advanced Drug Delivery

Ostrove, Steven

Harburn, Kenneth

Stokes, David

<p>The application of computational modeling and simulation has extended beyond PK/PD prediction of clinical trial outcomes by defining regulatory strategy as well as optimization of therapeutic candidates. Further, regulatory agencies are accepting modeling and simulation for approval in special populations, drug-drug interactions, and dosing regimen changes. This volume provides a comprehensive coverage of drug design, chemoinformatics, molecular modeling, and computer-aided formulation development. Computer simulations play a crucial role in the pharmaceutical industry, accelerating drug discovery and development by predicting drug behavior and optimizing systems, thus reducing the need for animal testing.</p><p><b>Key Features</b></p><ul> <li>Illustrates how computer simulations play a crucial role in the pharmaceutical industry, accelerating drug discovery and development.</li> <li>PK/PD simulations play a crucial role in optimizing dosing regimens and understanding the time course of drug effects.</li> <li>Depicts the role of computers in drug research development, both in clinical and preclinical stage by citing examples of approved FDA drugs.</li> <li>Provides case studies detailing the step-by-step process for using software such as Python for programming in the pharmaceutical industry; Gromacs, DataWarrior, AutoDock and Biovia.</li> <li>Discusses how artificial intelligence and machine learning can be used to optimize and refine simulation models.</li> </ul>

Klote, Molly

<p><i>An essential resource for a bioanalyst!</i></p><p>The Bioanalysis Glossary has been a trusted resource in the field for many years, with its content evolving through six editions in the Taylor & Francis Bioanalysis journal to reflect advancements in bioanalytical science. However, this marks the first time the glossary is being published as a standalone book by CRC Press/Taylor & Francis Group. As such, the publisher is presenting it as the 'First Edition', while acknowledging its rich history and prior iterations. To further distinguish this publication and align it with the current year, we are referring to it as the '2026 Edition'. This designation emphasizes the glossary's relevance and timeliness, ensuring readers understand that it incorporates the latest developments and terminology in bioanalysis.</p><p>This guide is intended to be of great benefit to individuals who are new to the field or working with bioanalytical laboratories for the first time. Additionally, this glossary serves as a valuable reference for experienced bioanalysts who are working on research papers, reports or presentations. Since its creation, the Bioanalysis Glossary's primary objective has been to facilitate the standardization of terminology used within the bioanalytical community, within and between companies, universities and individuals. In this increasingly globalized field, it has become necessary for scientists to speak the same bioanalytical language.</p><p><b>Key Features</b></p><ul> <li>The <i>Bioanalysis </i>and Bioanalysis Zone editorial teams are delighted to bring you the 2026 Edition of The Bioanalysis Glossary, which continues to be regarded as an essential resource for everyone who works in bioanalysis or adjacent fields.</li> </ul><ul> <li>A total of 15 leading experts in the bioanalytical field have been working closely with our editorial teams to provide a comprehensive update to the new edition of our glossary, reflecting the growing field of bioanalysis.</li> </ul><ul> <li>Describes closely related techniques, technologies and applications of bioanalysis, which are important or useful for bioanalysts to understand.</li> </ul><ul> <li>Covers (bio)analytical techniques and equipment, pharmacokinetics, clinical trials, metabolomics, antidoping testing, therapeutic drug monitoring, regulatory and validation terminology, drug development and statistical terminology.</li> </ul>